Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Thrivent Financial for Lutherans reduced its stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 33.0% in the fourth quarter, according to the company in its most recent 13F filing with ...

Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) have been given a consensus recommendation of “Moderate ...

In trading on Wednesday, shares of Denali Therapeutics Inc (Symbol: DNLI) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $13.86 per share.

Denali (DNLI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Denali Therapeutics (DNLI – Research Report) today. The company’s ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Denali Therapeutics (DNLI – Research Report), ...

One stock that might be an intriguing choice for investors right now is Denali Therapeutics Inc. DNLI. This is because this security in the Medical - Biomedical and Genetics space is seeing solid ...